ProQR Therapeutics N.V. buy Chardan Capital
Start price
08.11.23
/
50%
€1.27
Target price
08.11.24
€1.87
Performance (%)
44.79%
Price
10:30
€1.83
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital for ProQR Therapeutics N.V. has seen massive gains of 44.79%. This prediction currently runs until 08.11.24. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| ProQR Therapeutics N.V. | -1.057% | -1.057% |
| iShares Core DAX® | 0.476% | -0.039% |
| iShares Nasdaq 100 | 1.290% | 0.504% |
| iShares Nikkei 225® | 1.300% | -2.135% |
| iShares S&P 500 | 0.829% | 0.193% |
Comments by Chardan_Capital for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at Chardan Capital from a "neutral" rating to a "buy" rating. They now have a $2.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat